{
    "2018-07-30": [
        [
            {
                "time": "2018-07-26",
                "original_text": "How Celgene’s Otezla and Abraxane Did in Q2 2018",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Otezla",
                        "Abraxane",
                        "Q2",
                        "performance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "What's in the Cards for Conatus (CNAT) This Earnings Season?",
                "features": {
                    "keywords": [
                        "Conatus",
                        "earnings",
                        "season"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-31",
                "original_text": "Novartis Reports EU Approval Of Aimovig - Quick Facts",
                "features": {
                    "keywords": [
                        "Novartis",
                        "EU",
                        "approval",
                        "Aimovig"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates",
                "features": {
                    "keywords": [
                        "ImmunoGen",
                        "Q2",
                        "earnings",
                        "revenues",
                        "miss",
                        "estimates"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "A Look at Celgene’s Financials in Q2 2018",
                "features": {
                    "keywords": [
                        "Celgene",
                        "financials",
                        "Q2",
                        "2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "A Look at Teva’s Earnings Estimates ahead of Q2 Results",
                "features": {
                    "keywords": [
                        "Teva",
                        "earnings",
                        "estimates",
                        "Q2"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-25",
                "original_text": "Why Analysts Expect Teva’s Revenues to Fall in the Second Quarter",
                "features": {
                    "keywords": [
                        "analysts",
                        "Teva",
                        "revenues",
                        "fall",
                        "second quarter"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "The Swiss Stock Market Dipped As Defensive Heavyweights Fall",
                "features": {
                    "keywords": [
                        "Swiss",
                        "stock market",
                        "dipped",
                        "defensive",
                        "heavyweights"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "The Majority of Analysts Recommend a ‘Hold’ for Teva",
                "features": {
                    "keywords": [
                        "analysts",
                        "recommend",
                        "hold",
                        "Teva"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "The Swiss Stock Market",
                "features": {
                    "keywords": [
                        "Swiss",
                        "stock market"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "European Medicines Agency's CHMP Says Yes To 7 Drugs, No To 1",
                "features": {
                    "keywords": [
                        "European Medicines Agency",
                        "CHMP",
                        "drugs",
                        "approval"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}